Corneal Cross Linking

PROCEDURE5 trials

Sponsors

Medical University of Vienna, Democritus University of Thrace, Luca Buzzonetti, Instituto de Oftalmología Fundación Conde de Valenciana, Kasr El Aini Hospital

Conditions

Amount of Corneal Flattening (Kmax Flattening)Change in the Endothelial Cell CountKeratoconusPellucid Marginal Degeneration

Phase 3

Corneal Cross Linking and Topography Guided Excimer Laser Treatment

TerminatedNCT01682993

Medical University of ViennaKeratoconus, Pellucid Marginal Degeneration

Start: 2010-01-31End: 2015-12-31Updated: 2017-04-26

Unknown Phase

Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.

CompletedNCT01845714

Democritus University of ThraceKeratoconus

Start: 2009-04-30End: 2012-10-31Updated: 2017-01-18

Iontophoretic Transepithelial Corneal Cross-linking in Pediatric Patients

CompletedNCT03661164

Luca BuzzonettiKeratoconus

Start: 2013-05-01End: 2015-06-30Updated: 2018-09-11

Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus

Instituto de Oftalmología Fundación Conde de ValencianaKeratoconus

Start: 2023-03-01End: 2024-05-15Target: 20Updated: 2023-12-07

Topo-Pachymetric Customized Accelerated Epi-On Vs Accelerated Epi-Off Corneal Cross Linking in Keratoconus Management

Not yet recruitingNCT06549387

Kasr El Aini HospitalAmount of Corneal Flattening (Kmax Flattening), Change in the Endothelial Cell Count

Start: 2024-08-15End: 2025-04-30Target: 55Updated: 2024-08-12